BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugimoto N, Suzukawa M, Nagase H, Koizumi Y, Ro S, Kobayashi K, Yoshihara H, Kojima Y, Kamiyama-Hara A, Hebisawa A, Ohta K. IL-9 Blockade Suppresses Silica-induced Lung Inflammation and Fibrosis in Mice. Am J Respir Cell Mol Biol 2019;60:232-43. [PMID: 30240278 DOI: 10.1165/rcmb.2017-0287OC] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu W, Tian K, Li X, Zhang S. IL-9 blockade attenuates inflammation in a murine model of methicillin-resistant Staphylococcus aureus pneumonia. Acta Biochim Biophys Sin (Shanghai) 2020;52:133-40. [PMID: 31942919 DOI: 10.1093/abbs/gmz149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rojas-Quintero J, Wang X, Owen CA. Dusting Off IL-9 as a New Therapeutic Target for Pulmonary Fibrosis. Am J Respir Cell Mol Biol 2019;60:141-3. [PMID: 30281328 DOI: 10.1165/rcmb.2018-0319ED] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang T, Chai Z, Wang L, Liu B, Zhao J, Ren J, Yang B, Wei X, Jiang L, Liu F. IL-9 blockade attenuates inflammation in a murine model of mechanical ventilation-induced lung injury by inhibiting the NLRP3 inflammasome pathway. Inflammopharmacology 2022. [PMID: 35296962 DOI: 10.1007/s10787-022-00947-7] [Reference Citation Analysis]
4 Wu CL, Yin R, Wang SN, Ying R. A Review of CXCL1 in Cardiac Fibrosis. Front Cardiovasc Med 2021;8:674498. [PMID: 33996954 DOI: 10.3389/fcvm.2021.674498] [Reference Citation Analysis]
5 Adamcakova J, Mokra D. Herbal compounds in the treatment of pulmonary silicosis. Physiol Res 2021;70:S275-87. [PMID: 35099247 DOI: 10.33549/physiolres.934817] [Reference Citation Analysis]
6 Deng KM, Yang XS, Luo Q, She YX, Yu QY, Tang XX. Deleterious Role of Th9 Cells in Pulmonary Fibrosis. Cells 2021;10:3209. [PMID: 34831433 DOI: 10.3390/cells10113209] [Reference Citation Analysis]
7 Wan M, Han J, Ding L, Hu F, Gao P. Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis. Front Med (Lausanne) 2021;8:604894. [PMID: 33869241 DOI: 10.3389/fmed.2021.604894] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lu K, Du HT, Lian AL, Su Y, Wang F. Effect of purine-rich box1 on proliferation of fibroblasts. Int J Ophthalmol 2020;13:1827-32. [PMID: 33215017 DOI: 10.18240/ijo.2020.11.22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Lee J, Kim JH, Hong SH, Yang SR. Organoid Model in Idiopathic Pulmonary Fibrosis. Int J Stem Cells 2021;14:1-8. [PMID: 33122472 DOI: 10.15283/ijsc20093] [Reference Citation Analysis]
10 Ogawa T, Shichino S, Ueha S, Bando K, Matsushima K. Profibrotic properties of C1q+ interstitial macrophages in silica-induced pulmonary fibrosis in mice. Biochem Biophys Res Commun 2022;599:113-9. [PMID: 35180470 DOI: 10.1016/j.bbrc.2022.02.037] [Reference Citation Analysis]
11 Adamcakova J, Mokra D. New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis. Int J Mol Sci 2021;22:4162. [PMID: 33920534 DOI: 10.3390/ijms22084162] [Reference Citation Analysis]
12 Carai P, Ruozi G, Paye A, Debing Y, Bortolotti F, Lecomte J, Zentilin L, Jones EAV, Giacca M, Heymans S. AAV9-mediated functional screening for cardioprotective cytokines in Coxsackievirus-B3-induced myocarditis. Sci Rep 2022;12:7304. [PMID: 35508525 DOI: 10.1038/s41598-022-11131-w] [Reference Citation Analysis]
13 Montesi SB, Fisher JH, Martinez FJ, Selman M, Pardo A, Johannson KA. Update in Interstitial Lung Disease 2019. Am J Respir Crit Care Med 2020;202:500-7. [PMID: 32412784 DOI: 10.1164/rccm.202002-0360UP] [Reference Citation Analysis]
14 Gouyou B, Grün K, Kerschenmeyer A, Villa A, Matasci M, Schrepper A, Pfeil A, Bäz L, Jung C, Schulze PC, Neri D, Franz M. Therapeutic Evaluation of Antibody-Based Targeted Delivery of Interleukin 9 in Experimental Pulmonary Hypertension. Int J Mol Sci 2021;22:3460. [PMID: 33801620 DOI: 10.3390/ijms22073460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhang M, Zhang S. T Cells in Fibrosis and Fibrotic Diseases. Front Immunol 2020;11:1142. [PMID: 32676074 DOI: 10.3389/fimmu.2020.01142] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
16 Ruan H, Luan J, Gao S, Li S, Jiang Q, Liu R, Liang Q, Zhang R, Zhang F, Li X, Zhou H, Yang C. Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-β1 Signaling Pathway. Molecules 2021;26:4491. [PMID: 34361644 DOI: 10.3390/molecules26154491] [Reference Citation Analysis]
17 She YX, Yu QY, Tang XX. Role of interleukins in the pathogenesis of pulmonary fibrosis. Cell Death Discov 2021;7:52. [PMID: 33723241 DOI: 10.1038/s41420-021-00437-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Adamcakova J, Mokra D. Herbal Compounds in the Treatment of Pulmonary Silicosis. Physiol Res. [DOI: 10.33549/10.33549/physiolres.934817] [Reference Citation Analysis]
19 Ballester B, Milara J, Cortijo J. Mucins as a New Frontier in Pulmonary Fibrosis. J Clin Med 2019;8:E1447. [PMID: 31514468 DOI: 10.3390/jcm8091447] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]